Press release
Rising Eye Disorders and Ageing Population Drive Growth in Anterior Uveitis Market
Anterior Uveitis Market
Anterior uveitis, an inflammation of the front part of the eye, is becoming more common, with studies showing it causes nearly 10% of all blindness cases. A growing global population over the age of 60 is especially vulnerable to such eye conditions. According to the World Health Organization, this age group will grow from 900 million in 2015 to 2 billion by 2050 - a demographic shift that significantly increases demand for eye care services and targeted treatments.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/3979
As people age, their immune systems weaken, making them more susceptible to diseases like anterior uveitis. Older adults often require frequent medical checkups and specialized treatments, pushing healthcare providers and pharmaceutical companies to invest in age-specific therapies. This is expected to accelerate market growth over the coming years.
Another key driver is the growing incidence of eye disorders linked to modern lifestyle changes, urban living, and environmental factors. As awareness increases, more people are seeking diagnosis and treatment. Medical professionals and researchers are responding by developing advanced therapies and incorporating technologies like telemedicine and digital health tools to improve accessibility.
According to the College of Optometrists, anterior uveitis affects about 12 out of every 100,000 people each year. The International Agency for the Prevention of Blindness also reports a sharp rise in glaucoma cases-from 20 million in 2010 to 80 million by 2020-highlighting the broader trend of growing eye health concerns.
Despite the growing demand, the high cost of treatment remains a major barrier for many patients. Managing anterior uveitis often involves expensive medications and ongoing care, which can lead some to delay or avoid treatment altogether. In areas with limited health coverage, this cost burden limits access and hampers market growth. Addressing these financial challenges is crucial for expanding access to care and ensuring long-term market development.
In terms of market segmentation, non-infectious uveitis emerged as the leading category in 2024. A long-term study conducted at the University Hospital of Ioannina in Greece found that 66.6% of uveitis cases were non-infectious. Ongoing progress in treatment has further boosted this segment. For example, in August 2023, Tarsier Pharma Ltd. reported strong Phase III clinical trial results for its TRS01 eye drops in treating non-infectious anterior uveitis.
Meanwhile, infectious uveitis is expected to be the fastest-growing segment in the coming years. The rise in uveitis linked to viral infections is driving innovation in diagnostics and treatment methods. According to research published by Elsevier B.V. in June 2024, the global prevalence of infectious uveitis ranges from 3.5% to 58%, with higher rates seen in developing nations. This highlights the urgent need for accessible treatments in regions with limited medical infrastructure.
Get a Discount On The Purchase Of This Report @ https://www.emergenresearch.com/request-discount/3979
Anterior Uveitis Market Top Companies and Competitive Landscape
Market competition in the Anterior Uveitis industry is characterized by the presence of global and regional players such as Novartis AG, Santen Pharmaceutical Co., Ltd., AbbVie Inc., Kiora Pharmaceuticals, Inc., and others. The global Anterior Uveitis market is relatively fragmented, with a high level of competition.
Key companies are actively involved in developing innovative therapies to meet the growing demand for effective treatment options. Players focus on a variety of approaches, including corticosteroids, immunosuppressants, and biologics, in order to manage inflammation and improve patient outcomes.
Advances in drug delivery systems and personalised medicine are increasingly becoming the focus of this market. Strategic collaborations, mergers, and acquisitions are common as the companies continue to develop their product portfolios and expand their market reach.
In January 2024, Tarsier Pharma Ltd. got FDA approval for the Tarsier-04 Phase 3 clinical study of TRS01 eye drop through a Special Protocol Assessment (SPA).
Some of the key companies in the global Anterior Uveitis market include:
Novartis AG
Santen Pharmaceutical Co., Ltd.
AbbVie Inc.
Kiora Pharmaceuticals, Inc.
Clearside Biomedical
Aldeyra Therapeutics, Inc.
Aciont Inc.
Sirion Therapeutics, Inc.
UCB S.A.
Lux Biosciences, Inc.
Tarsier Pharma Ltd.
Anterior Uveitis Market Latest Industry Updates
In October 2023, Clearside Biomedical, Inc.'s partner, ARCTIC VISION HONG KONG BIOTECH LIMITED, reported the conclusion of a phase III trial of ARCATUS (ARVN001) for uveitic macular edema treatment via suprachoroidal injection.
In April 2023, the European Commission granted Novartis AG's division "Sandoz" a marketing license to enhance Hyrimoz's distribution. This license covers all of the reference medicine's indications for different disorders, including uveitis.
In February 2023, Santen Pharmaceutical revealed encouraging top-line results from the Phase 3 trial of ALTAIR for the treatment of anterior uveitis.
Interested in knowing more relevant information? Click here: https://www.emergenresearch.com/industry-report/anterior-uveitis-market
Anterior Uveitis Market Segmentation Analysis
Type Outlook (Revenue, USD Billion; 2020-2033)
Infectious Uveitis
Non-Infectious Uveitis
Anterior Uveitis
Pan-Uveitis
Posterior Uveitis
Intermediate Uveitis
Therapy Outlook (Revenue, USD Billion; 2020-2033)
Corticosteroids
Immunosuppressive therapies
Biologics
Others
Pipeline Therapies
Distribution Channel Outlook (Revenue, USD Billion; 2020-2033)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional Outlook (Revenue, USD Billion; 2020-2033)
North America
United States
Canada
Mexico
Europe
Germany
France
United Kingdom
Italy
Spain
Benelux
Rest of Europe
Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America
Brazil
Rest of Latin America
Middle East and Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of MEA
Buy the full research report at @ https://www.emergenresearch.com/select-license/3979
Radical Features of the Anterior Uveitis Market Report:
The report encompasses Anterior Uveitis market overview along with market share, demand and supply ratio, production and consumption patterns, supply chain analysis, and other ley elements
An in-depth analysis of the different approaches and procedures undertaken by the key players to conduct business efficiently
Offers insights into production and manufacturing value, products and services offered in the market, and fruitful information about investment strategies
Supply chain analysis along with technological advancements offered in the report
The report covers extensive analysis of the trends, drivers, restraints, limitations, threats, and growth opportunities in the Anterior Uveitis industry
Look Over transcripts provided by Emergen Research
Anterior Uveitis Market Size@ https://www.emergenresearch.com/industry-report/anterior-uveitis-market/market-size
Anterior Uveitis Market Share@ https://www.emergenresearch.com/industry-report/anterior-uveitis-market/market-share
Anterior Uveitis Market Trends@ https://www.emergenresearch.com/industry-report/anterior-uveitis-market/market-trends
Anterior Uveitis Regional Market Demand@ https://www.emergenresearch.com/industry-report/anterior-uveitis-market/regional-market-demand
Anterior Uveitis Market Analysis@ https://www.emergenresearch.com/industry-report/anterior-uveitis-market/market-analysis
Contact Us:
14671 110 Avenue, Surrey, British Columbia, V3R2A9
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Eye Disorders and Ageing Population Drive Growth in Anterior Uveitis Market here
News-ID: 3961301 • Views: …
More Releases from Emergen Research
Global Internet of Things (IoT) in Healthcare Market to Reach USD 299.05 Billion …
The global Internet of Things (IoT) in Healthcare Market was valued at USD 299.05 billion in 2023 and is expected to grow at a CAGR of 16.5% during the forecast period. This growth is fueled by the rising use of connected healthcare devices, increasing demand for early disease detection through remote monitoring, and growing adoption of artificial intelligence (AI) tools within IoT-based healthcare systems.
The market is also benefiting from the…
Global Stem Cell Therapy Market to Reach USD 49.2 Billion by 2034, Growing at 13 …
The global Stem Cell Therapy Market, valued at USD 13.7 billion in 2024, is projected to reach USD 49.2 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.6%. Growth is being fueled by the rising burden of chronic diseases, rapid progress in cell-based studies, and increasing investments in regenerative medicine and personalized healthcare solutions.
Stem cell therapies offer the ability to repair, replace, or restore damaged tissues…
Artificial Intelligence Strengthens Cybersecurity as Threats Grow More Sophistic …
The global Artificial Intelligence in cybersecurity market size was USD 23.8 Billion in 2023 and is expected to reach a market valuation of USD 29.44 billion by the end of 2024 registering a CAGR of 23.7% during the forecast period. The adoption of Artificial Intelligence (AI) in cybersecurity is rapidly gaining traction as organizations worldwide face increasingly complex and frequent cyber threats. By combining advanced technologies such as Machine Learning…
Global Regenerative Medicine Market to Reach USD 125.6 Billion by 2034, Growing …
The global regenerative medicine market, valued at USD 34.2 billion in 2024, is set to grow to USD 125.6 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.9%. Growth is being fueled by rising approvals of advanced therapies, strong demand for personalized treatments in cancer and orthopedics, and expanding cell and gene therapy manufacturing across major markets such as North America, Europe, and Asia.
Once seen as…
More Releases for Uveitis
Uveitis Market : An Overview Report
Introduction:
Uveitis is an inflammatory condition affecting the uvea, the middle layer of the eye. It can lead to vision impairment or even blindness if left untreated. Uveitis is categorized into different types, including anterior, intermediate, posterior, and panuveitis, depending on the part of the eye affected. The condition can be caused by infections, autoimmune diseases, or trauma. With increasing cases of autoimmune disorders and infectious diseases, the prevalence of uveitis…
Uveitis Treatment Market Size, Share | Trend 2030
Exclusive Report by Ameco Research: Uveitis Treatment Market Size Projected to Reach USD 2 Billion by 2030, Growing at 6% CAGR
Ameco Research is proud to announce the launch of its latest market research report, Uveitis Treatment Market. This comprehensive report provides in-depth analysis and insights into the current market trends and future projections in the Industry/Market Segment. Ameco Research has been at the forefront of providing quality market research…
Uveitis - Drug Pipeline Landscape, 2022
New York, Global Insight Services have recently published a report on Uveitis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Uveitis is an inflammation of the eye which damages the part of the eye called the uvea and affects other parts of the eyes which causes pain to the eyes. There are 4 types of…
Uveitis - Drug Pipeline Landscape, 2022
Global Insight Services have recently published a report on Uveitis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Uveitis is an inflammation of the eye which damages the part of the eye called the uvea and affects other parts of the eyes which causes pain to the eyes. There are 4 types of uveitis based…
Japan Industry Statistics of Uveitis Treatment
Global Uveitis Treatment Market: Overview
Uveitis, an autoimmune eye disease, is considered rare for just around 38 in 100,000 people are afflicted by it. Because of this, it is often overlooked. Patients afflicted by uveitis are often referred to an expert after much delay on account of less awareness about the eye malady. This delays timely diagnosis and results in irreversible damage to various ocular structures.
Read Report Overview: https://www.transparencymarketresearch.com/uveitis-treatment-market.html
As per Cochrane,…
Uveitis Treatment Market Analysis of Top industry Scenario
Global Uveitis Treatment Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables).
According to a new report published by Allied Market Research, titled, "Uveitis Treatment Market by Drug Class (Anti-inflammatory, Antimicrobial Drugs, Immunotherapy &…
